Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001075087 | SCV001240698 | pathogenic | Retinal dystrophy | 2018-07-16 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001377625 | SCV001575007 | likely pathogenic | Zellweger spectrum disorders | 2022-03-08 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 217429). This missense change has been observed in individual(s) with a peroxisomal biogenesis disorder, Zellweger syndrome spectrum (PMID: 26387595). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs370483961, gnomAD 0.0009%). This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 581 of the PEX1 protein (p.Arg581Pro). |
Fulgent Genetics, |
RCV002500626 | SCV002809821 | likely pathogenic | Peroxisome biogenesis disorder 1A (Zellweger); Heimler syndrome 1; Peroxisome biogenesis disorder 1B | 2021-10-10 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000201302 | SCV004203303 | likely pathogenic | Heimler syndrome 1 | 2023-08-14 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000201302 | SCV000256090 | pathogenic | Heimler syndrome 1 | 2015-10-01 | no assertion criteria provided | literature only | |
Natera, |
RCV001377625 | SCV002076892 | likely pathogenic | Zellweger spectrum disorders | 2020-10-16 | no assertion criteria provided | clinical testing |